The U.S. Supreme Court ruled that generic-drug companies, unlike their brand-name rivals, can’t be sued for failing to warn patients about the risk of dangerous side effects.
The 5-4 ruling bars two women from suing units of Mylan Inc. and Teva Pharmaceutical Industries Ltd. over metoclopramide, a stomach drug they say caused them to contract a severe neurological disorder.
